The US Food and Drug Administration’s (FDA) has approved a technology called atrial fibrillation-detection technology. It measures heart rate.
Under the new technology, Fitbit notes the heartbeat and its fluctuations several times a day with intervals and in case of a dangerous condition, checks to see if the heart condition is being affected. This condition is called arterial fibrillation. On the one hand, this condition can lead to paralysis and on the other hand, it can lead to death.
With the Fitbit software, patients themselves can know their condition, otherwise it is possible for the device to stay in the background and note the condition and heartbeat.
Fitbit introduced this feature in 2020. When it was tested on several people, it identified several cases of irregular heartbeat with 98% accuracy and it was possible to save the lives of these patients. Then there’s the Apple Watch. Since then, Apple has repeatedly approached the FDA for its watch. Two months ago, Apple again asked the FDA to approve its general use in light of the new evidence.
Although Fitbit devices are still less effective than conventional devices, they can be used to refer patients to the hospital for immediate medical attention by identifying dangerous symptoms. Experts believe that wearing a Fitbit can help heart patients detect atrial fibrillation immediately. In this way the condition of the heart can be constantly monitored.
Fitbit has announced that it will be the first company to release this kind of watch to the American public after approval.
Fitbit is a Google-owned wearable brand.